ARTICLE | Finance
JOBS Jolt 3.0?
Assessing the benefits of JOBS 3.0 for biotechs looking to go public
July 20, 2018 10:52 PM UTC
The latest iteration of the JOBS Act could make it easier for biotechs to go public -- and raise more money more quickly -- but that doesn’t necessarily mean the quality of the IPO queue will be diluted.
The House of Representatives voted 406-4 on Tuesday to pass the JOBS and Investor Confidence Act of 2018, or JOBS Act 3.0, a collection of 32 bills that expands upon provisions enacted in 2012 (see “Tear Down That Wall”)...